Phase Ib Trial of Finotonlimab Combined With <scp>SCT200</scp> in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Jinguan Lin, Song Qu, Kunyu Yang, Tao Zhang, Yuansong Bai, Jian Wu, Yanjing Huang, Meiyu Fang, Xianling Liu, Xiaoming Huang, Nianyong Chen, Zhendong Li, Weidong Li, Songnan Zhang, Shurong Zhang, Guangyuan Hu, Yan Sun, Xiaohong Chen, Yanyan Liu, Shanghua Jing, Liangfang Shen, Zhiwei Chang, Liangzhi Xie, Wenlin Gai, Yan Wang, Xinyue Chen, Dongfang Liu, Ye Guo

Open source

DOI: 10.1002/cam4.72272
Published: 2026-09
Container: Cancer Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72272,
  title = {Phase Ib Trial of Finotonlimab Combined With
                    <scp>SCT200</scp>
                    in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma},
  author = {Jinguan Lin and Song Qu and Kunyu Yang and Tao Zhang and Yuansong Bai and Jian Wu and Yanjing Huang and Meiyu Fang and Xianling Liu and Xiaoming Huang and Nianyong Chen and Zhendong Li and Weidong Li and Songnan Zhang and Shurong Zhang and Guangyuan Hu and Yan Sun and Xiaohong Chen and Yanyan Liu and Shanghua Jing and Liangfang Shen and Zhiwei Chang and Liangzhi Xie and Wenlin Gai and Yan Wang and Xinyue Chen and Dongfang Liu and Ye Guo},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.72272},
  url = {https://doi.org/10.1002/cam4.72272}
}

RIS

TY  - JOUR
TI  - Phase Ib Trial of Finotonlimab Combined With
                    <scp>SCT200</scp>
                    in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
AU  - Jinguan Lin
AU  - Song Qu
AU  - Kunyu Yang
AU  - Tao Zhang
AU  - Yuansong Bai
AU  - Jian Wu
AU  - Yanjing Huang
AU  - Meiyu Fang
AU  - Xianling Liu
AU  - Xiaoming Huang
AU  - Nianyong Chen
AU  - Zhendong Li
AU  - Weidong Li
AU  - Songnan Zhang
AU  - Shurong Zhang
AU  - Guangyuan Hu
AU  - Yan Sun
AU  - Xiaohong Chen
AU  - Yanyan Liu
AU  - Shanghua Jing
AU  - Liangfang Shen
AU  - Zhiwei Chang
AU  - Liangzhi Xie
AU  - Wenlin Gai
AU  - Yan Wang
AU  - Xinyue Chen
AU  - Dongfang Liu
AU  - Ye Guo
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.72272
UR  - https://doi.org/10.1002/cam4.72272
ER  -

APA

Lin, J., Qu, S., Yang, K., Zhang, T., Bai, Y., Wu, J., Huang, Y., Fang, M., Liu, X., Huang, X., Chen, N., Li, Z., Li, W., Zhang, S., Zhang, S., Hu, G., Sun, Y., Chen, X., Liu, Y., Jing, S., Shen, L., Chang, Z., Xie, L., Gai, W., Wang, Y., Chen, X., Liu, D., & Guo, Y. (2026). Phase Ib Trial of Finotonlimab Combined With <scp>SCT200</scp> in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.72272

Source records

crossref · retrieved 2026-09-25T07:32:03.585Z